Sensorion Announces Approval to Initiate Lead Gene Therapy Candidate SENS-501 (OTOF-GT) into a Phase 1/2 Clinical Trial in some European Countries
Sensorion notes This gene therapy for patients suffering from otoferlin [...]
Sensorion notes This gene therapy for patients suffering from otoferlin [...]
The AVANT GUARD clinical trial will evaluate the safety and [...]
YOLT-201 Injection utilizes several lipid components including ionizable lipids as [...]
“It is encouraging to see positive initial safety results in [...]
“The completion of the APEX-AV Study represents an important milestone [...]
Data from clinical studies of STK-001 demonstrated clinical benefit for [...]
The findings suggest that the novel, non-invasive genomic test can [...]
Xeltis, a leading developer of transformative implants that enable the [...]
The two presentations were made at the VEITHsymposium, a major [...]
This collaboration will enable clinical trial sponsors to quantify the [...]